US › Healthcare

Neuronetics Inc (STIM)

US · Healthcare · Medical Devices

$2.97+7.61%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$41.6M

Revenue YoY

+9.1%

Net profit

$-3.4M

EPS

$-0.05

EPS estimate

$-0.11

Net margin

-8.3%

EPS came in at -0.05 against a street estimate of -0.11 — a beat of 54.5%.

Key statistics

Market cap

$230.9M

Forward P/E

0.0

P/B

12.93

Book value

$0.23

EPS (TTM)

$-0.43

52-week high

$3.44

52-week low

$0.80

50-day MA

$2.40

200-day MA

$1.73

Beta

1.17

Analyst view

Analysts rate Neuronetics Inc a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $6.00.

Shareholding

Insiders

30.85%

Institutions

54.00%

Largest institutional holders

Fund	Stake
Madryn Asset Management, LP	24.33%
UBS Group AG	3.77%
Balyasny Asset Management LLC	3.60%
BlackRock Inc	3.04%
Vanguard Capital Management, LLC	2.69%
Wexford Capital LP	2.63%
FourWorld Capital Management LLC	2.29%
Lane Generational LLC	2.14%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neuronetics Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.